{
  "meta": {
    "title": "274_Obstetrics_And_Gynecology_Aiims_2020_May_And_Nov_Ini-Cet",
    "url": "https://brainandscalpel.vercel.app/274-obstetrics-and-gynecology-aiims-2020-may-and-nov-ini-cet-e41ffa62.html",
    "scrapedAt": "2025-11-30T12:57:42.635Z"
  },
  "questions": [
    {
      "text": "The following groups of people must be screened for Ca cervix:",
      "choices": [
        {
          "id": 1,
          "text": "More than 65 years old"
        },
        {
          "id": 2,
          "text": "Less than 21 years old"
        },
        {
          "id": 3,
          "text": "21 to 65 year old females"
        },
        {
          "id": 4,
          "text": "Teenagers"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Screening for cervical cancer is done in females aged&nbsp;<strong>21 to 65 years.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age Group</strong></td>\n<td><strong>Screening Recommendations</strong></td>\n</tr>\n<tr>\n<td>&lt;21 years</td>\n<td>Do not screen&nbsp;</td>\n</tr>\n<tr>\n<td>21-29 years&nbsp;</td>\n<td>Cytologic testing (Pap smear) every 3 years</td>\n</tr>\n<tr>\n<td>30-65 years</td>\n<td>\n<p>Preferred: Cytologic and HPV co-testing every 5 years&nbsp;</p>\n<p>Alternative: Cytologic testing every 3 years</p>\n</td>\n</tr>\n<tr>\n<td>&gt;65 years</td>\n<td>Discontinue screening if sufficient negative screening results* present, and if there is no history of HSIL, adenocarcinoma in situ, or cancer.</td>\n</tr>\n<tr>\n<td>&nbsp;\n<div class=\"page\" title=\"Page 422\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Women who have undergone total hysterectomy with removal of cervix&nbsp;</p>\n</div>\n</div>\n</div>\n</td>\n<td>Discontinue screening</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;*Three consecutive negative cytologic tests or two consecutive negative co-tests within the past 10 years, with the most recent test occurring within the past 5 years</p><hr><h3>Related Pearl: Grades of cervical dysplasia</h3><p>A comparison of various naming systems based on cytology (Bethesda) and biopsy (CIN grade)</p>\n<table>\n<tbody>\n<tr>\n<td><strong>WHO grade</strong></td>\n<td><strong>Bethesda</strong></td>\n<td><strong>CIN grade</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>Mild Dysplasia</td>\n<td>LSIL</td>\n<td>CIN I</td>\n<td>Dysplastic cells in basal 1/3 of cervical epithelium</td>\n</tr>\n<tr>\n<td>Moderate Dysplasia</td>\n<td rowspan=\"3\">HSIL</td>\n<td>CIN II</td>\n<td>Dysplastic cells in basal 2/3 of cervical epithelium</td>\n</tr>\n<tr>\n<td>Severe dysplasia</td>\n<td>CIN III</td>\n<td>Dysplastic cells in &gt;2/3 of the cervical epithelium</td>\n</tr>\n<tr>\n<td>Carcinoma in situ</td>\n<td>Carcinoma in situ</td>\n<td>Dysplastic cells in full-thickness of cervical epithelium but basement membrane is intact</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>LSIL</strong></td>\n<td><strong>HSIL</strong></td>\n</tr>\n<tr>\n<td>Atypia confined to the basal one-third of the epithelium</td>\n<td>Atypia involving upper two-third of the epithelium</td>\n</tr>\n<tr>\n<td>80% of LSILs are associated with high-risk HPVs, mostly HPV-16</td>\n<td>100% of HSILs are associated with high-risk HPVs, mostly HPV-16</td>\n</tr>\n<tr>\n<td>60% regress spontaneously; only 10% progress to HSIL.</td>\n<td>30% regress spontaneously; 10% progress to carcinoma</td>\n</tr>\n<tr>\n<td>Not a premalignant lesion</td>\n<td>Premalignant lesion</td>\n</tr>\n<tr>\n<td>Next step - Colposcopic directed biopsy</td>\n<td>Next step -&nbsp;Colposcopic directed biopsy + Endocervical curettage</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Abbreviations:</p>\n<p>CIN: Cervical Intra-epithelial neoplasia</p>\n<p>LSIL: Low Squamous Intra-epithelial Lesion</p>\n<p>HSIL: High&nbsp;Squamous Intra-epithelial Lesion</p><hr><h3>Related Pearl: Standard staging procedure of Ca Cervix by FIGO guidelines</h3><div class=\"page\" title=\"Page 4\"><strong>Physical examination</strong></div>\n<ul>\n<li class=\"bulletIndent1\">Speculum, bimanual, and rectovaginal examination- For pelvic examination (primary tumor, uterus, vagina, and parametria)</li>\n<li class=\"bulletIndent1\">Palpation of groin and supraclavicular lymph nodes, examination of the right upper quadra- For distant metastases.</li>\n</ul>\n<p><strong>Cervical biopsy</strong></p>\n<ul>\n<li>Colposcopy with directed cervical biopsy or cervical biopsy without colposcopy</li>\n<li>Endocervical curettage</li>\n<li>Conization</li>\n</ul>\n<p><strong>Endoscopy</strong></p>\n<ul>\n<li>Hysteroscopy</li>\n<li>Cystoscopy</li>\n<li>Proctoscopy</li>\n</ul>\n<p><strong>Imaging studies</strong></p>\n<ul>\n<li>Intravenous pyelogram/CT/MR &ndash; Evaluation for urinary tract obstruction</li>\n<li>Plain/skeletal radiograph &ndash; Evaluation for metastases.</li>\n</ul>\n<p><strong>&nbsp;If readily available and accessible</strong></p>\n<ul>\n<li>CT / PETCT &ndash; For assessing pelvic and paraaortic lymph node involvement.</li>\n<li>MRI - To assess tumor size and local extent of disease.</li>\n<li>Ultrasound &ndash; This may also be used to assess tumor size and local extent of disease.</li>\n</ul>\n<p><strong>Image-guided&nbsp;biopsy -&nbsp;</strong>If imaging shows sites suspicious for metastatic disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4694",
      "difficulty": "easy"
    },
    {
      "text": "Oral contraceptives act by all of the following mechanisms except:",
      "choices": [
        {
          "id": 1,
          "text": "Inhibit  implantation"
        },
        {
          "id": 2,
          "text": "Cervical mucus thickening"
        },
        {
          "id": 3,
          "text": "Inhibit ovulation"
        },
        {
          "id": 4,
          "text": "Increase GnRH release"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Oral contraceptive pills </strong>(OCPs)&nbsp;do not cause an increase in GnRH, they <strong>inhibit the release of GnRH.</strong></p>\n<p>OCPs act via the following mechanisms:</p>\n<ul>\n<li><strong>Inhibiting ovulation</strong> - Both estrogen and progesterone act on the hypothalamic-pituitary axis to <strong>inhibit the release of GnRH</strong> (and thus subsequently LH and FSH). Seen in combined oral pills.</li>\n<li><strong>Preventing implantation</strong> - Under the effect of OCPs, <strong>endometrial stroma</strong> undergoes <strong>hypoplasia</strong>, with atrophy of glands. This makes it unfavorable for implantation of the embryo. Seen primarily with mifepristone, but is a secondary mechanism of action with&nbsp;progesterone-only pills as well.</li>\n<li><strong>Cervical mucus </strong>becomes<strong> thick and scanty</strong> under the effect of progesterone. This makes it <strong>difficult</strong> for <strong>sperm</strong> to enter. Seen in progesterone-only pills.</li>\n</ul><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Oral contraceptive use is associated with a decreased risk of ovarian &amp; endometrial cancer according to a recent analysis. At the same time, OCP use is associated with short-term increased risk of breast cancer after discontinuation, although the lifetime risk of breast cancer is not significantly different.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:33555261,&quot;3&quot;:{&quot;1&quot;:0},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0,&quot;28&quot;:1}\">Oral contraceptive use is associated with a <strong>decreased</strong> risk of <strong>ovarian</strong> &amp; <strong>endometrial</strong> cancer according to a recent analysis. At the same time, OCP use is associated with short-term <strong>increased</strong> risk of <strong>breast</strong> cancer after discontinuation, although the lifetime risk of breast cancer is not significantly different.</span></p><hr><h3>Related Pearl: Hormonal contraceptives</h3><div dir=\"ltr\">\n<p><strong>Oral pills:</strong></p>\n<ul>\n<li>Combined oral contraceptive pills (COC)\n<ul>\n<li>Mala D -&nbsp;Levonorgestrel 0.15 mg + Ethinyl estradiol &nbsp;0.03 mg + Ferrous fumarate</li>\n<li>Mala N -&nbsp;Levonorgestrel 0.15 mg +&nbsp;Ethinyl estradiol &nbsp;0.03 mg + Ferrous fumarate&nbsp;(Govt. supply, free of cost)</li>\n</ul>\n</li>\n<li>Progesterone only pills (POP) - suitable for lactating women\n<ul>\n<li>Norethisterone 350 &mu;g</li>\n<li>Norgestrel 75 &mu;g</li>\n<li>Levonorgestrel (LNG) 30 &mu;g</li>\n</ul>\n</li>\n<li>Once a month or long-acting pills - highly disappointing results\n<ul>\n<li>Quinestrol (long-acting estrogen) + short-acting progesterone</li>\n</ul>\n</li>\n<li>Gossypol - male pill : Cottonseed derivative and causes azoospermia and severe oligospermia</li>\n<li>Post-coital pills or interceptive\n<ul>\n<li>Levonorgestrel 0.75 mg, 2 doses, 12 hours apart</li>\n<li>Mifepristone 10-600 mg</li>\n<li>Ulipristal 30 mg, within 5 days of intercourse</li>\n<li>Centchroman 60 mg, 2 tablets, within 24 hrs of intercourse</li>\n<li>GnRH agonists &nbsp;</li>\n<li>CuT IUCD, inserted within 5 days</li>\n</ul>\n</li>\n</ul>\n<p><strong> Injectable contraceptives</strong></p>\n<ul>\n<li>Progesterone only injectables\n<ul>\n<li>DMPA&nbsp;150 mg IM every 3 months</li>\n<li>NET-EN&nbsp;200 mg IM every 2 months</li>\n</ul>\n</li>\n<li>Combined injectables\n<ul>\n<li>Cyclofem - DMPA 25 mg + Estradiol cypionate 5 mg</li>\n<li>Mesigyna - NET-EN 50 mg &nbsp;+ Estradiol valerate 5 mg</li>\n</ul>\n</li>\n</ul>\n<p><strong> Subdermal implants</strong></p>\n<ul>\n<li>Norplant I -&nbsp;Levonorgestrel 35 mg</li>\n<li>Norplant II or Jadelle -&nbsp;2 rods with levonorgestrel 70 mg in each and released at a rate of 50 &mu;g/day &nbsp;</li>\n</ul>\n<p><strong>Others</strong></p>\n<ul>\n<li>Hormonal IUCD -&nbsp;Mirena which contains LNG 52 mg with release rate of&nbsp;20 &mu;g/day</li>\n<li>Orthoevra patch -&nbsp;Norelgestomin + Ethinyl estradiol weekly for 3 weeks, then patch free for 1 week</li>\n<li>Vaginal ring or Nuvaring - Etonogestrel + ethinyl estradiol daily release, use for 3 weeks with withdrawal for 1 week</li>\n</ul>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4692",
      "difficulty": "easy"
    },
    {
      "text": "A 30-year-old woman is diagnosed with a high-grade squamous intraepithelial lesion (HSIL) of the cervix and no obvious macroscopic growth. What is the next line of management?",
      "choices": [
        {
          "id": 1,
          "text": "Hysterectomy"
        },
        {
          "id": 2,
          "text": "Conization"
        },
        {
          "id": 3,
          "text": "Colposcopy and biopsy"
        },
        {
          "id": 4,
          "text": "Follow-up after 6 months"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In a woman diagnosed with a&nbsp;<strong>high-grade squamous intraepithelial lesion</strong> (HSIL), the next step in management is to perform a&nbsp;<strong>colposcopy and biopsy.</strong></p>\n<p>Patients who are found to have HSIL are further subjected to biopsy. This is done by&nbsp;<strong>colposcopic study</strong>&nbsp;for the visual inspection with acetic acid (<strong>VIA</strong>) for<strong>&nbsp;aceto-white</strong> <strong>areas</strong>&nbsp;and taking biopsies of abnormal areas.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/26931a1b2b9e4dccb6bfa54c90857433x1280x1886.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Grades of cervical dysplasia</h3><p>A comparison of various naming systems based on cytology (Bethesda) and biopsy (CIN grade)</p>\n<table>\n<tbody>\n<tr>\n<td><strong>WHO grade</strong></td>\n<td><strong>Bethesda</strong></td>\n<td><strong>CIN grade</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>Mild Dysplasia</td>\n<td>LSIL</td>\n<td>CIN I</td>\n<td>Dysplastic cells in basal 1/3 of cervical epithelium</td>\n</tr>\n<tr>\n<td>Moderate Dysplasia</td>\n<td rowspan=\"3\">HSIL</td>\n<td>CIN II</td>\n<td>Dysplastic cells in basal 2/3 of cervical epithelium</td>\n</tr>\n<tr>\n<td>Severe dysplasia</td>\n<td>CIN III</td>\n<td>Dysplastic cells in &gt;2/3 of the cervical epithelium</td>\n</tr>\n<tr>\n<td>Carcinoma in situ</td>\n<td>Carcinoma in situ</td>\n<td>Dysplastic cells in full-thickness of cervical epithelium but basement membrane is intact</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>LSIL</strong></td>\n<td><strong>HSIL</strong></td>\n</tr>\n<tr>\n<td>Atypia confined to the basal one-third of the epithelium</td>\n<td>Atypia involving upper two-third of the epithelium</td>\n</tr>\n<tr>\n<td>80% of LSILs are associated with high-risk HPVs, mostly HPV-16</td>\n<td>100% of HSILs are associated with high-risk HPVs, mostly HPV-16</td>\n</tr>\n<tr>\n<td>60% regress spontaneously; only 10% progress to HSIL.</td>\n<td>30% regress spontaneously; 10% progress to carcinoma</td>\n</tr>\n<tr>\n<td>Not a premalignant lesion</td>\n<td>Premalignant lesion</td>\n</tr>\n<tr>\n<td>Next step - Colposcopic directed biopsy</td>\n<td>Next step -&nbsp;Colposcopic directed biopsy + Endocervical curettage</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Abbreviations:</p>\n<p>CIN: Cervical Intra-epithelial neoplasia</p>\n<p>LSIL: Low Squamous Intra-epithelial Lesion</p>\n<p>HSIL: High&nbsp;Squamous Intra-epithelial Lesion</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4599",
      "difficulty": "medium"
    },
    {
      "text": "A patient with 6 weeks amenorrhea and a positive pregnancy test came with complaints of lower abdominal pain, moderate bleeding PV. She was hemodynamically stable. On USG, there was no gestational sac in the uterus. Ovaries were normal and no free fluid in the pouch of Douglas. What is the next line of management?",
      "choices": [
        {
          "id": 1,
          "text": "Declare as complete abortion and follow-up in 15 days"
        },
        {
          "id": 2,
          "text": "Admit and observe"
        },
        {
          "id": 3,
          "text": "Diagnostic laparoscopy"
        },
        {
          "id": 4,
          "text": "Follow-up with beta-HCG"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The patient presents with a history of 6 weeks of <strong>amenorrhea</strong>, a<strong> positive urine pregnancy test</strong>, <strong>abdominal pain</strong> and <strong>moderate vaginal bleeding</strong>. However, the <strong>ultrasound examination does not reveal a gestational sac</strong> in the uterus, which could indicate either an<strong> ectopic pregnancy</strong> or an <strong>abortion</strong>. In such cases, the next line of management is to <strong>follow up with beta-HCG</strong> (human chorionic gonadotropin) levels.</p>\n<p>Beta-HCG levels<strong> above 1500 mIU/mL</strong> are considered the <strong>discriminatory value</strong>, beyond which a gestational sac should be visible on transvaginal ultrasound.</p>\n<p>If the gestational sac is not visible on ultrasound and the beta-HCG levels are <strong>above 1500 mIU/mL</strong>, it suggests an <strong>ectopic pregnancy</strong>. On the other hand, if the beta-HCG levels are <strong>below 1500 mIU/mL</strong>, they can be <strong>repeated after 48 hours</strong> and interpreted as follows:</p>\n<ul>\n<li><strong>Decreasing HCG levels</strong> between day 1 and day 3 suggest a possible <strong>abortion</strong>.</li>\n<li>If the <strong>HCG levels rise</strong> during this period but does not double, it indicates a likely <strong>ectopic pregnancy</strong>.</li>\n</ul>\n<p><strong>Note</strong>: While some institutions set the discriminatory threshold for HCG levels at ≥ 1500 mIU/mL, others use ≥ 2000 mIU/mL.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4539",
      "difficulty": "easy"
    },
    {
      "text": "A hypertensive pregnant woman with abdominal pain, bleeding per vaginum, and loss of fetal movements. What is the probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Abruptio placenta"
        },
        {
          "id": 2,
          "text": "Placenta previa"
        },
        {
          "id": 3,
          "text": "Hydramnios"
        },
        {
          "id": 4,
          "text": "Preterm labour"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical picture with<strong> abdominal pain</strong>, <strong>bleeding per vaginum</strong>, and <strong>loss of fetal movements</strong> in a <strong>hypertensive pregnant woman</strong> points to the diagnosis of <strong>placental abruption.&nbsp;&nbsp;</strong></p>\n<p><strong>Placenta previa</strong> (option B) refers to when the placenta is implanted partially or completely over the internal os and it usually presents with <strong>painless</strong> vaginal bleeding.</p>\n<p><strong>Hydramnios</strong> (option C) refers to a state where the volume of amniotic fluid exceeds 2000mL and it does not present with bleeding per vaginum.&nbsp;</p>\n<p>In <strong>preterm labor</strong> (option D) fetal movements are not compromised.&nbsp;</p>\n<p>Abruptio placenta is the <strong>partial/total placental separation</strong> from its implantation site <strong>before delivery</strong>. The bleeding may be:</p>\n<ul>\n<li><strong>Revealed</strong>&nbsp;(blood dissects downwards between membranes and uterine wall to escape through the cervix)&nbsp;</li>\n<li><strong>Concealed</strong> (blood accumulates between the detached placenta and uterus)</li>\n</ul>\n<p><strong>Hypertension</strong> in pregnancy is the most important risk factor for abruptio placenta.&nbsp;Patients often present with&nbsp;sudden onset abdominal pain, vaginal bleeding,&nbsp;uterine tenderness, and frequent contractions.&nbsp;</p>\n<p>The hemorrhage into decidua basalis causes separation and compression of the placenta. This leads to a <strong>compromise</strong> of circulation to the&nbsp;<strong>fetus</strong>, leading to <strong>fetal</strong> <strong>distress.</strong></p>\n<p>Clinical classification of placental abruption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Grade 1</strong></td>\n<td><strong>Grade 2</strong></td>\n<td><strong>Grade 3</strong></td>\n</tr>\n<tr>\n<td><strong>Vaginal bleeding</strong> is slight</td>\n<td>Vaginal bleeding mild to moderate</td>\n<td>Bleeding is moderate to severe or concealed.</td>\n</tr>\n<tr>\n<td>\n<p>Uterus irritable, minimal tenderness</p>\n</td>\n<td><strong>Uterine tenderness</strong> is always present</td>\n<td>Uterine tenderness is marked.</td>\n</tr>\n<tr>\n<td>Maternal BP and fibrinogen unaffected</td>\n<td>Maternal pulse increased, BP maintained</td>\n<td>Shock is pronounced</td>\n</tr>\n<tr>\n<td>FHS good</td>\n<td><strong>Fetal distress present</strong></td>\n<td>Fetal death is the rule</td>\n</tr>\n<tr>\n<td>Maternal shock absent</td>\n<td>Maternal shock absent</td>\n<td>Associated coagulation defect or anuria may complicate</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4531",
      "difficulty": "easy"
    },
    {
      "text": "A 30-year-old woman visits an infertility clinic. She has a regular 28-day cycle. How should she be evaluated?",
      "choices": [
        {
          "id": 1,
          "text": "Serum progesterone on day 14"
        },
        {
          "id": 2,
          "text": "Serum progesterone on day 21"
        },
        {
          "id": 3,
          "text": "Serum LH on day 14"
        },
        {
          "id": 4,
          "text": "Serum LH on day 21"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Serum progesterone </strong>on<strong> day 21</strong> should be evaluated in this woman to check for anovulatory cycles.&nbsp;&nbsp;</p>\n<p><strong>Anovulation</strong> is the major cause of female infertility. Therefore, tests are done to rule out anovulatory defects in a woman presenting with infertility.&nbsp;</p>\n<p>After ovulation, the plasma concentration of progesterone increases and reaches its peak during the <strong>mid-luteal</strong> phase. Serum progesterone levels are assessed on <strong>day 8</strong> and <strong>day 21</strong> of a 28-day cycle. If the progesterone value increases from less than 1 ng/mL to greater than 6 ng/mL, it indicates ovulation. Subsequently, as the corpus luteum degenerates, progesterone levels decline.</p>\n<p>If the plasma progesterone level remains low during the mid-luteal phase, it suggests a&nbsp;<strong>corpus luteal phase defect</strong> and indicates the need for hormonal therapy.</p>\n<div class=\"page\" title=\"Page 216\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Daily estimation</strong> of <strong>serum LH</strong>&nbsp;(options C and D) around the midcycle can detect the <strong>LH surge</strong>. Ovulation coincides about 10 to 12 hours after the LH peak.</p>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4528",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old woman presents with abnormal uterine bleeding for two months. What is the next line of management?",
      "choices": [
        {
          "id": 1,
          "text": "LNG- IUCD"
        },
        {
          "id": 2,
          "text": "POP for 3 months"
        },
        {
          "id": 3,
          "text": "Hysterectomy"
        },
        {
          "id": 4,
          "text": "Endometrial sampling"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The next line of management in a<strong> 50-year-old woman </strong>with<strong> abnormal uterine bleeding&nbsp;</strong>is&nbsp;<strong>endometrial sampling</strong>.</p>\n<p>Indications for<strong> endometrial sampling</strong>:</p>\n<ul>\n<li>Any <strong>female &gt; 45 years with abnormal uterine bleeding</strong></li>\n<li>A female of age &lt; 45 years having <strong>exposure to excessive estrogen</strong> such as in <strong>PCOD</strong>, severe <strong>obesity</strong>, tamoxifen treatment</li>\n<li>Women with failed medical management and persistent bleeding</li>\n<li>Transvaginal ultrasound findings&nbsp;<strong>&gt;12 mm in premenopausal women</strong> and<strong> &gt; 4 mm in postmenopausal women.</strong></li>\n</ul>\n<p>Endometrial sampling may be done by either curettage or aspiration biopsy by pipelle or vibra aspirator.</p>\n<p>Note: <strong>Transvaginal ultrasound</strong> is a better <strong>first-line</strong> investigation to assess AUB. Since TVS is not included in the options, endometrial sampling is the next best answer. Assessing the reason for AUB and ruling out malignancy in the postmenopausal age group are the initial steps before prescribing any treatment.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4519",
      "difficulty": "easy"
    },
    {
      "text": "A patient with 12 weeks amenorrhea presents with vaginal bleeding. On examination, the cervical os is open and the uterus is of 14 weeks size. USG shows a snowstorm appearance. The next best step in the management is?",
      "choices": [
        {
          "id": 1,
          "text": "Medical management"
        },
        {
          "id": 2,
          "text": "Follow up with beta-hCG"
        },
        {
          "id": 3,
          "text": "Suction and evacuation"
        },
        {
          "id": 4,
          "text": "Hysterectomy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario of <strong>vaginal bleeding</strong>, an<strong> enlarged uterus</strong> <strong>exceeding the corresponding period of amenorrhea</strong>, and a<strong> snowstorm appearance</strong> on USG strongly indicates a diagnosis of a<strong> hydatidiform mole</strong>.&nbsp;<strong>Suction and evacuation</strong> is the next best step in the management of this patient.</p>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p><strong>Hydatidiform mole</strong> is an abnormal condition of the&nbsp;<strong>placenta,&nbsp;</strong>characterized by&nbsp;partly <strong>degenerative</strong> and&nbsp;partly&nbsp;<strong>proliferative </strong>changes in the chorionic villi. It may be either partial or complete.</p>\n<p>The patient presents with a characteristic history of abdominal pain, <strong>vaginal bleeding</strong> or spotting, and vomiting during the first trimester. Also, there may be a history of passing <strong>grape-like vesicles</strong> vaginally. On examination, the size of the uterus is <strong>larger for gestational age</strong> and the fetal heart sounds are absent.</p>\n<p>A USG scan shows a <strong><span class=\"notion-enable-hover\" data-token-index=\"1\" data-reactroot=\"\">snowstorm appearance</span></strong> which is characteristic of a <strong>complete mole</strong>.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c859612450c4425b9502ffaf05dbf8a5x720x605.JPEG\" alt=\"Explanation Image\"><p><strong>Suction and evacuation</strong> is the treatment of choice. <strong>Hysterectomy </strong>(option D)&nbsp;is done only if there is uncontrolled hemorrhage or perforation during surgical evacuation or if the age of the patient is above 35 years and has completed her family.</p>\n<p>Serum hCG levels (option B) are checked <strong>within 48 hours</strong> of evacuation and are used as a <strong>baseline</strong> for future comparisons. It is then checked <strong>every week till it normalizes</strong>, which usually takes around 4 to 8 weeks. After the hCG values return to normal, a regular follow-up is done <strong>monthly for 6 months.</strong></p><hr><h3>Related Pearl: Complete vs. Partial Mole</h3><p>Hydatidiform mole is a <strong>benign</strong> abnormal condition of the placenta characterized by partial degenerative or proliferative changes of the <strong>chorionic villi</strong>. Though benign, it has malignant potential. It is commonly seen in pregnancies of extreme reproductive age groups - <strong>teenage</strong> and women <strong>above 35 years</strong> of age. A previous <strong>history of molar pregnancy</strong> is also a strong risk factor for recurrence of this condition.</p>\n<p>Molar pregnancy is of 2 types - complete mole and partial mole.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>Partial mole</strong></td>\n<td><strong>Complete mole</strong></td>\n</tr>\n<tr>\n<td><strong>Karyotype</strong></td>\n<td>69 XYY or 69 XXY</td>\n<td>46 XX or 46 XY</td>\n</tr>\n<tr>\n<td><strong>Diagnosis</strong></td>\n<td>Missed abortion</td>\n<td>Molar gestation</td>\n</tr>\n<tr>\n<td><strong>Uterus size</strong></td>\n<td>Small for date</td>\n<td>Large for date</td>\n</tr>\n<tr>\n<td><strong>Theca-lutein cysts</strong></td>\n<td>Rare</td>\n<td>25&ndash;30% of cases</td>\n</tr>\n<tr>\n<td><strong>Initial hCG levels</strong></td>\n<td>&lt;1 lakh mIU/ml</td>\n<td>&gt;1 lakh mIU/ml</td>\n</tr>\n<tr>\n<td><strong>Medical complications</strong></td>\n<td>Rare</td>\n<td>Uncommon</td>\n</tr>\n<tr>\n<td><strong>Rate of subsequent GTN</strong></td>\n<td>1&ndash;5%</td>\n<td>15&ndash;20%</td>\n</tr>\n<tr>\n<td><strong>Embryo-fetus</strong></td>\n<td>&nbsp;Often present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Amnion, fetal erythrocytes</strong></td>\n<td>Often present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Villous edema</strong></td>\n<td>&nbsp;Focal</td>\n<td>Widespread</td>\n</tr>\n<tr>\n<td><strong>Trophoblastic proliferation</strong></td>\n<td>Focal, slight to moderate</td>\n<td>Slight to severe</td>\n</tr>\n<tr>\n<td><strong>Trophoblast atypia</strong></td>\n<td>Mild</td>\n<td>Marked</td>\n</tr>\n<tr>\n<td><strong>p57KIP2 immunostaining</strong></td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/abb92edd8fe94b1997c1f9c5bf1a559ex1280x2039.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4449",
      "difficulty": "easy"
    },
    {
      "text": "A 45-year-old woman is found to have a fibroid of 14 weeks size. She has no specific symptoms. What is the next step in management?",
      "choices": [
        {
          "id": 1,
          "text": "Hysterectomy"
        },
        {
          "id": 2,
          "text": "Myomectomy"
        },
        {
          "id": 3,
          "text": "Observation"
        },
        {
          "id": 4,
          "text": "Medical management"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In this 45-year-old woman (&gt;40 years) with an <strong>asymptomatic</strong> <strong>fibroid</strong> of 14-week size, the next best step in management would be <strong>observation</strong>. </p>\n<p>Fibroids/leiomyomas are slow-growing benign tumours thus regardless of their size asymptomatic fibroids are managed conservatively with observation and annual checkups. </p>\n<p><strong>Indications</strong> for the <strong>treatment</strong> of fibroids are:</p>\n<ul>\n<li>Abnormal uterine bleeding</li>\n<li>A rapid increase in the growth of fibroid</li>\n<li>Infertility</li>\n<li>Chronic pelvic pain/ bulk symptoms</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: Hysterectomy is usually reserved as the definitive treatment of choice for women who have <strong>completed</strong> their <strong>family</strong> and <strong>do</strong> <strong>not</strong> wish to <strong>preserve</strong> their <strong>fertility</strong>.</p>\n<div class=\"page\" title=\"Page 177\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option B: Myomectomy is a surgical procedure that involves removing fibroids while preserving the uterus. It is indicated in an<strong> infertile woman</strong> or a <strong>woman desirous of childbearing</strong> and wishing to retain the uterus.</p>\n<div class=\"page\" title=\"Page 181\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option D: Medical therapy aims to <strong>control menorrhagia</strong> in cases of <strong>symptomatic fibroids</strong>, improve haemoglobin levels before surgery, and shrink the fibroids before procedures such as myomectomy.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4432",
      "difficulty": "medium"
    },
    {
      "text": "All of the following structures are cut in mediolateral episiotomy except?",
      "choices": [
        {
          "id": 1,
          "text": "Transverse perineal  muscles"
        },
        {
          "id": 2,
          "text": "Obturator muscle"
        },
        {
          "id": 3,
          "text": "Bulbospongiosus"
        },
        {
          "id": 4,
          "text": "Transverse perineal branches of pudendal  nerves"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>All the mentioned structures are cut in mediolateral episiotomy except for the&nbsp;<strong>o</strong><strong>bturator muscle.</strong></p>\n<p><strong>Episiotomy&nbsp;</strong>refers to the surgically planned incision on the perineum and the posterior vaginal wall during&nbsp;the second stage of labor.&nbsp;The objective is to enlarge the vaginal introitus so as to facilitate easy and safe delivery of the fetus and to <strong>minimize overstretching</strong> and <strong>rupture</strong> of the perineal muscles and fascia, which might end up in complete tears.</p>\n<p>In <strong>mediolateral episiotomy</strong>,<em>&nbsp;</em>the incision is made downwards and outwards from the midpoint of the fourchette&nbsp;either to the right or to the left. The other types of episiotomy include median, lateral, and J shaped episiotomy.</p>\n<p>Structures cut in mediolateral&nbsp;episiotomy are:</p>\n<ul>\n<li>Posterior vaginal wall</li>\n<li>Superficial and deep <strong>transverse perineal muscles </strong>(option A)</li>\n<li><strong>Bulbospongiosus</strong> and part of levator ani (option C)</li>\n<li>Fascia covering these muscles</li>\n<li><strong>Transverse perineal branches of&nbsp;pudendal</strong> vessels and <strong>nerves </strong>(option D)</li>\n<li>Subcutaneous tissue and skin</li>\n</ul>\n<p>Differences between midline and mediolateral episiotomy include:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Midline Episiotomy</strong></td>\n<td><strong>Mediolateral Episiotomy</strong></td>\n</tr>\n<tr>\n<td>Surgical repair is easy</td>\n<td>Surgical repair is difficult</td>\n</tr>\n<tr>\n<td>Blood loss is lesser</td>\n<td>Blood loss is more</td>\n</tr>\n<tr>\n<td>Healing is superior</td>\n<td>Healing is not so good</td>\n</tr>\n<tr>\n<td>Dyspareunia is rare</td>\n<td>Dyspareunia is comparatively more</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Postoperative comfort is maximum</p>\n</td>\n<td>\n<p class=\"p1\">Postoperative discomfort is more</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Extension, if occurs, may involve the rectum</p>\n</td>\n<td>\n<p class=\"p1\">Relative safety from rectal involvement from extension&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"p2\">&nbsp;</p>\n</div>\n</div><hr><h3>Related Pearl: Mediolateral Episiotomy</h3><p>It begins within 3 mm of the midline in the posterior fourchette and is directed laterally at an angle of at least <strong>60 degrees</strong> from the midline. This yields an incision of&nbsp;<strong>45</strong>&nbsp;<strong>degrees</strong> off the midline.</p>\n<p>It is essentially an inflicted second-degree perineal tear.</p>\n<p><strong>Structures cut in mediolateral episiotomy:</strong></p>\n<ul>\n<li>Posterior vaginal wall</li>\n<li>Superficial and deep transverse perineal muscles, bulbospongiosus and part of levator ani</li>\n<li>Fascia covering those muscles</li>\n<li>Transverse perineal branches of pudendal vessels and nerves</li>\n<li>Subcutaneous tissue and skin</li>\n</ul>\n<p><strong>Advantage:</strong> Lesser risk of&nbsp;anal sphincter laceration, hence&nbsp;it is<strong>&nbsp;preferred </strong>over median episiotomy.</p>\n<p><strong>Disadvantage:</strong> Increased blood loss and causes more perineal pain and dyspareunia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3b63de15769847739008d216f6d7b34cx1280x1669.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Degrees of perineal laceration</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Degree</strong></div>\n</td>\n<td>\n<div class=\"bulletIndent1\"><strong>Description</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>First-degree</strong></div>\n</td>\n<td>\n<div class=\"bulletIndent1\">Injury to the skin and subcutaneous tissue of the perineum and vaginal epithelium only. The perineal muscles remain intact.</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Second-degree</strong></div>\n</td>\n<td>\n<div>Extends into the fascia and musculature of the perineal body. The anal sphincter muscles remain intact.</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<div><strong>Third-degree</strong> </div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3a</div>\n</td>\n<td>\n<div>&lt;50% of EAS thickness is torn</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3b</div>\n</td>\n<td>\n<div>&gt;50% of EAS thickness is torn</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3c</div>\n</td>\n<td>\n<div>Both EAS and IAS are torn</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Fourth-degree</strong></div>\n</td>\n<td>\n<div>Involves the perineal structures, EAS, IAS and rectal mucosa.</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<div class=\"page\" title=\"Page 214\"> </div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/01962269ebc64dcd8bcc84c2720ecd2bx1280x7974.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4380",
      "difficulty": "medium"
    },
    {
      "text": "Raise in ESR during pregnancy is due to?",
      "choices": [
        {
          "id": 1,
          "text": "Albumin"
        },
        {
          "id": 2,
          "text": "Platelet"
        },
        {
          "id": 3,
          "text": "Fibrinogen"
        },
        {
          "id": 4,
          "text": "Anti-thrombin antibody"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Raised ESR</strong>&nbsp;in pregnancy is due to an&nbsp;<strong>increase</strong>&nbsp;in <strong>fibrinogen</strong> and <strong>globulin</strong> levels.</p>\n<p>Pregnancy&nbsp;is a <strong>hypercoagulable state</strong>. The fibrinogen level&nbsp;is raised by 50% during&nbsp;pregnancy.&nbsp;As a result of rise in fibrinogen and globulin level&nbsp;and diminished blood viscosity, <strong>erythrocyte&nbsp;</strong><strong>sedimentation rate (ESR)</strong> gives a much higher&nbsp;value <strong>(fourfold increase)</strong> during pregnancy.</p>\n<p><strong>Total plasma protein&nbsp;increases</strong> during pregnancy. However, due to hemodilution, plasma protein concentration falls. This results in diminished viscosity of&nbsp;the blood and reduced colloid osmotic tension.&nbsp;Because of marked <strong>fall in albumin level</strong>&nbsp;and only slight&nbsp;rise of globulin (mainly alpha-globulin), the normal <strong>albumin: globulin ratio</strong> of 1.7:1 is <strong>diminished&nbsp;</strong>to 1:1.</p><hr><h3>Related Pearl: Hematological changes in pregnancy</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Increases</strong></p>\n</td>\n<td>\n<p><strong>Decreases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemoglobin <strong>mass</strong></p>\n</td>\n<td>\n<p>Hemoglobin <strong>concentration</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total plasma protein</strong></p>\n</td>\n<td>\n<p><strong>S.urea/creatinine/uric acid</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Globulin</strong></p>\n</td>\n<td>\n<p>Albumin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neutrophils</p>\n</td>\n<td>\n<p>Platelets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fibrinogen</strong></p>\n</td>\n<td>\n<p><strong>Blood urea nitrogen</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Factors 7,8,9,10</strong></p>\n</td>\n<td>\n<p>Factor 11,13</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Insulin</strong></p>\n</td>\n<td>\n<p>S.Na/K/Ca/Mg/I<sub>2</sub></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL,HDL,apolipoprotiens</p>\n</td>\n<td>\n<p>-</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>S.Transferrin</strong> and TIBC(Total</p>\n<p>Iron binding capcity)</p>\n</td>\n<td>\n<p>S.Iron, ferritin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>CRP(C-Reactive protein)</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Placental phosphatase</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total alkaline phosphatase</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>ESR 4x rise</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4379",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following criteria is used for diagnosing abdominal pregnancy?",
      "choices": [
        {
          "id": 1,
          "text": "Spiegelberg's criteria"
        },
        {
          "id": 2,
          "text": "Rubin's criteria"
        },
        {
          "id": 3,
          "text": "Studdiford's criteria"
        },
        {
          "id": 4,
          "text": "Godin's criteria"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Studdiford's criteria</strong> is used in the diagnosis of<strong>&nbsp;primary abdominal&nbsp;</strong><strong>pregnancy.</strong>&nbsp;It includes:</p>\n<ul>\n<li>Presence of <strong>normal</strong> tubes and ovaries with no evidence of recent or past injury/pregnancy.</li>\n<li><strong>Absence</strong> of&nbsp;uteroperitoneal fistula.</li>\n<li>Presence of a pregnancy related <strong>exclusively</strong> to the peritoneal surface and early&nbsp;enough to eliminate the possibility of secondary implantation&nbsp;after primary tubal nidation.</li>\n</ul>\n<p>Other options:</p>\n<p>Option A:<strong> Spiegelberg&rsquo;s criteria&nbsp;</strong>is used in the diagnosis of <strong>ovarian pregnancy:</strong></p>\n<ul>\n<li>Tube on the affected side must be <strong>intact.</strong></li>\n<li>The gestation sac must be in the position of the <strong>ovary.</strong></li>\n<li>The gestation sac is connected to the uterus by the <strong>ovarian</strong> ligament.</li>\n<li><strong>Ovarian tissue</strong> must be found on its wall on histological examination.</li>\n</ul>\n<p>Option B:<strong> Rubin's criteria</strong><strong>&nbsp;</strong>is used in the diagnosis of<strong>&nbsp;cervical pregnancy:</strong></p>\n<ul>\n<li>Soft, <strong>enlarged</strong> cervix equal to or larger than the fundus.</li>\n<li>Uterine <strong>bleeding</strong> following amenorrhea,<strong> without</strong> cramping pain.</li>\n<li>Products of conception are entirely confined <strong>within</strong> and firmly attached to endocervix.</li>\n<li>A <strong>closed internal</strong> cervical os and a <strong>partially</strong> opened <strong>external</strong> os.</li>\n</ul>\n<p>Option D:<strong>Godin's sonographic criteria</strong> is used for the diagnosis of&nbsp;a <strong>cesarean scar pregnancy:</strong></p>\n<ul>\n<li><strong>Empty</strong> uterine cavity</li>\n<li><strong>Empty</strong> cervical canal</li>\n<li>A gestational sac in the <strong>anterior</strong> part of the uterine isthmus</li>\n<li><strong>Absence</strong> of healthy myometrium between the bladder and gestational sac</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4376",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a component of fetal biophysical profile?",
      "choices": [
        {
          "id": 1,
          "text": "Fetal movement"
        },
        {
          "id": 2,
          "text": "Fetal breathing"
        },
        {
          "id": 3,
          "text": "NST"
        },
        {
          "id": 4,
          "text": "Contraction stress test"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>contraction stress test</strong>&nbsp;is not a component of the biophysical profile.</p>\n<p>Biophysical profile is a multi-parametric&nbsp;<strong>screening test</strong>&nbsp;to assess <strong>uteroplacental insufficiency</strong>. It consists of&nbsp;<strong>five components </strong>and&nbsp;the observations are made for 30 minutes.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Parameters</strong></td>\n<td><strong>Minimal Normal Criteria</strong></td>\n</tr>\n<tr>\n<td><strong>Non-stress Test (NST) &nbsp;</strong></td>\n<td>&ge;2 accelerations within 20-40 minutes.</td>\n</tr>\n<tr>\n<td><strong>Fetal breathing movements &nbsp;</strong></td>\n<td>&ge; 1 episode of rhythmic breathing lasting &gt; 30 seconds.</td>\n</tr>\n<tr>\n<td><strong>Gross body movements &nbsp;</strong></td>\n<td>&ge; 3 discrete body/limb movements</td>\n</tr>\n<tr>\n<td><strong>Fetal muscle tone &nbsp;</strong></td>\n<td>&ge; 1 episode of active extension(limb or trunk) with return of flexion.</td>\n</tr>\n<tr>\n<td><strong>Amniotic fluid&nbsp;volume</strong></td>\n<td>A pocket of amniotic fluid that measures at least 2 cm in two perpendicular planes (2 &times;2 cm pocket)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Each parameter has a&nbsp;<strong>maximum score of 2</strong>&nbsp;and a&nbsp;<strong>minimum score of 0.&nbsp;</strong>So the total maximum score will be 10. A <strong>score of 4 or less</strong> indicates fetal <strong>acidemia</strong>.</p>\n<p>Interpretation and management of BPP scores:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>BPP score</strong></td>\n<td><strong>Interpretation</strong></td>\n<td><strong>Management</strong></td>\n</tr>\n<tr>\n<td><strong>10</strong></td>\n<td>Normal, nonasphyxiated fetus</td>\n<td>Repeat test weekly&nbsp;</td>\n</tr>\n<tr>\n<td><strong>8</strong>&nbsp;<strong>with normal AFV</strong></td>\n<td>Normal, nonasphyxiated fetus</td>\n<td>Repeat test weekly</td>\n</tr>\n<tr>\n<td><strong>8 with decreased AFV</strong></td>\n<td>Suspicion of chronic fetal asphyxia</td>\n<td>\n<div class=\"page\" title=\"Page 405\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>If &ge;36 weeks, delivery is done</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>6</strong></td>\n<td>Possible fetal asphyxia</td>\n<td>\n<p>If AFV is abnormal-Deliver&gt;36 weeks.</p>\n<p>If AFV is normal- deliver&ge; 37 weeks.&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>4</strong></td>\n<td>Probable fetal asphyxia</td>\n<td>\n<div class=\"page\" title=\"Page 405\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>If &ge;32 weeks, deliver</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>0-2</strong></td>\n<td>Almost certain fetal asphyxia</td>\n<td>Delivery&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>The modified biophysical score&nbsp;</strong>has only 2 components i.e&nbsp;<strong>NST</strong> and <strong>amniotic fluid index </strong>(AFI). It<strong>&nbsp;</strong>is considered abnormal (nonreassuring) when the NST is non-reactive and/or the AFI is &lt;5.</p>\n<p>Note: The <strong>contraction&nbsp;stress test </strong>(oxytocin challenge test)<strong>&nbsp;</strong>is an invasive method to assess fetal well-being during pregnancy. When there is an alteration in FHR in response&nbsp;to uterine contractions, it suggests fetal hypoxia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4372",
      "difficulty": "easy"
    },
    {
      "text": "All of the following can be used for the treatment of PCOD except?",
      "choices": [
        {
          "id": 1,
          "text": "Clomiphine citrate"
        },
        {
          "id": 2,
          "text": "Letrozole"
        },
        {
          "id": 3,
          "text": "Ulipristal"
        },
        {
          "id": 4,
          "text": "Laparoscopic ovarian drilling"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Ulipristal&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:16897,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0,&quot;17&quot;:1}\"><strong>Ulipristal</strong> is not used for the treatment of polycystic ovarian disease (PCOD). It is a synthetic progesterone hormone receptor modulator used as an <strong>emergency contraceptive pill</strong>.</span></p>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Ulipristal&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:16897,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0,&quot;17&quot;:1}\">PCOD is a complex multisystemic endocrine disorder affecting women of reproductive age. </span></p>\n<p><strong>Rotterdam criteria</strong> is used to diagnose PCOD. The presence of<strong> two of the three</strong> components of this criteria establishes the diagnosis.</p>\n<div class=\"page\" title=\"Page 326\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Oligo/amenorrhoea, anovulation, infertility</li>\n<li>Hirsutism/acne</li>\n<li>Ultrasound findings:\n<ul>\n<li>Enlarged ovaries with ovarian volume will be <strong>more than 10 mL</strong></li>\n<li><strong>12 or more </strong>small follicles each of <strong>2-9 mm</strong> in size placed peripherally</li>\n</ul>\n</li>\n</ul>\n<p><strong>Clomiphene</strong> (option A) is a selective estrogen receptor modulator that is used as the first line of treatment in managing infertility. Clomiphene with dexamethasone improves the fertility rate. In resistant cases, tamoxifen or <strong>letrozole</strong> (an aromatase inhibitor) (option B) can be tried. </p>\n</div>\n</div>\n</div>\n<p>Surgical management of PCOD includes <span class=\"Apple-converted-space\"><strong>laparoscopic ovarian drilling </strong>(option D)<strong>. </strong></span>Indications of surgery are:</p>\n<ul>\n<li>Failed medical therapy</li>\n<li>Hyperstimulation occurs</li>\n<li>Infertile women</li>\n<li>Previous pregnancy losses</li>\n</ul><hr><h3>Related Pearl: Management of PCOD</h3><table>\n<tbody>\n<tr>\n<td><strong>Complaint</strong></td>\n<td><strong>Management</strong> &nbsp;</td>\n</tr>\n<tr>\n<td>Irregular periods</td>\n<td>OCPs</td>\n</tr>\n<tr>\n<td>Obesity</td>\n<td>Lifestyle modification</td>\n</tr>\n<tr>\n<td>Insulin resistance</td>\n<td>Metformin</td>\n</tr>\n<tr>\n<td>Hirsutism /acne</td>\n<td>OCPs with cyproterone acetate</td>\n</tr>\n<tr>\n<td>Infertility</td>\n<td>Clomiphene</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Letrozole is as effective as Clomiphene in treating infertility in PCOD with fewer side effects. However, it's pending FDA approval and is used off-label.</p><hr><h3>Related Pearl: Endocrinological changes of PCOD</h3><ol>\n<li>Elevated Estrone/E1 levels.</li>\n<li>LH level is raised over 10 IU/mL. FSH level remains normal to low, but<strong> FSH/LH ratio falls.</strong></li>\n<li>Testosterone and epi-androstenedione levels rise.<br />\n<ul>\n<li><strong>Testosterone elevated but &lt; 200 ng/dL </strong>(normal range 20 -80 ng/dL)</li>\n<li>Testosterone &gt; 200 ng/dL suggests androgen-secreting ovarian tumor</li>\n<li>DHEA-S values may be normal or slightly elevated</li>\n<li>DHEA &gt;700 ng/mL suggests adrenal tumour</li>\n</ul>\n</li>\n<li>Serum SHBG is reduced.</li>\n<li><strong>Triglyceride level &gt;150 mg/dL</strong>-hyperlipidaemia HDL &lt;50 mg/dL.</li>\n<li>Fasting blood glucose/fasting insulin &lt;4.5 suggests insulin resistance</li>\n<li>Prolactin is mildly raised in 15% cases</li>\n<li><strong>Fasting insulin is more than 10 mIU/L in PCOS in 50–70%cases</strong></li>\n<li>Thyroid function tests may be abnormal (hypothyroidism)</li>\n<li>17-a-hydroxyprogesterone in the follicular phase &gt;300 ng/dL suggests adrenal hyperplasia due to 21-hydroxylase deficiency.</li>\n<li><strong>Urinary cortisol &lt;50 μg/24 h.</strong></li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4370",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a component of the Bishop score?",
      "choices": [
        {
          "id": 1,
          "text": "Cervical length"
        },
        {
          "id": 2,
          "text": "Type of maternal pelvis"
        },
        {
          "id": 3,
          "text": "Cervical position"
        },
        {
          "id": 4,
          "text": "Dilatation of cervix"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The type of maternal pelvis&nbsp;is not a component of the Bishop score.</p>\n<p>The<strong> Bishop score</strong> is a scoring system used to assess&nbsp;labor induction outcomes. It is based on the station of the head, dilation, effacement (or length), position, and consistency of the cervix noted by doing a vaginal examination.</p>\n<p>Note:&nbsp;In the&nbsp;<strong>modified Bishop score</strong>&nbsp;(1991), the effacement is&nbsp;<strong>replaced</strong>&nbsp;by the&nbsp;<strong>cervical length</strong>&nbsp;in cm.</p><hr><h3>Related Pearl: Bishop’s Score (Modified)</h3><table>\n<tbody>\n<tr>\n<td><strong>Score</strong></td>\n<td><strong>0</strong></td>\n<td><strong>1</strong></td>\n<td><strong>2</strong></td>\n<td><strong>3</strong></td>\n</tr>\n<tr>\n<td><strong>Dilatation (cm)</strong></td>\n<td>Closed</td>\n<td>1-2</td>\n<td>3-4</td>\n<td>5+</td>\n</tr>\n<tr>\n<td><strong>Cervical length (cm)</strong></td>\n<td>&gt;4</td>\n<td>2-4</td>\n<td>1-2</td>\n<td>&lt;1</td>\n</tr>\n<tr>\n<td><strong>Consistency</strong></td>\n<td>Firm</td>\n<td>Medium</td>\n<td>Soft</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Position</strong></td>\n<td>Posterior</td>\n<td>Midline</td>\n<td>Anterior</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Head-Station</strong></td>\n<td>-3</td>\n<td>-2</td>\n<td>-1, 0</td>\n<td>+1, +2</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Total score = 13</p>\n<p><strong>Favourable</strong>= 6-13</p>\n<p><strong>Unfavourable</strong>= 0-5</p>\n<p><strong>Note:</strong>&nbsp;</p>\n<ul>\n<li>According to NICE guidelines, a score of&nbsp;<strong>6-13</strong>&nbsp;is favorable for induction of labour.</li>\n<li>According to Williams Obstetrics (26th edition), a score of <strong>9 or more</strong> indicates a high likelihood of successful induction.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4179",
      "difficulty": "easy"
    },
    {
      "text": "A nursing assistant posted in the obstetric care unit was asked to monitor the progress of labour. After how much dilatation of the cervix, should she start the documentation?",
      "choices": [
        {
          "id": 1,
          "text": "2cm"
        },
        {
          "id": 2,
          "text": "5cm"
        },
        {
          "id": 3,
          "text": "4cm"
        },
        {
          "id": 4,
          "text": "6cm"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The WHO Labour Care Guide <strong>begins</strong> the <strong>documentation</strong> of labour progression at <strong>5 cm </strong>of <strong>cervical dilatation</strong>.</p>\n<p>The WHO Labour Care Guide is a tool designed to help health personnel involved in labour care. It aims to </p>\n<ul>\n<li>Guide the <strong>monitoring</strong> and help in the <strong>documentation</strong> of the progress of labour.</li>\n<li>Guide the health professionals to offer <strong>supportive</strong> <strong>care</strong> throughout labour.</li>\n<li>Assist doctors in promptly <strong>identifying</strong> and <strong>addressing</strong> emerging <strong>labour</strong> <strong>complications</strong>.</li>\n<li><strong>Prevent</strong> the use of <strong>unnecessary</strong> <strong>interventions</strong> in labour.</li>\n<li>Support <strong>audits</strong> and <strong>quality</strong> <strong>improvement</strong>.</li>\n</ul>\n<p>The differences between the WHO-modified partograph and the <strong>latest WHO Labour Care Guide </strong>are tabulated below: </p>\n<table>\n<tbody>\n<tr>\n<td><strong>WHO modified partograph</strong></td>\n<td><strong>WHO Labour Care Guide</strong></td>\n</tr>\n<tr>\n<td>Documentation of labour progression begins at <strong>4 cm</strong> of cervical dilatation.</td>\n<td>Documentation of labour progression begins at <strong>5 cm</strong> of cervical dilatation.</td>\n</tr>\n<tr>\n<td>Fixed <strong>1 cm/hour ‘alert’ and ‘action’</strong> lines</td>\n<td><strong>Time-based cut-offs</strong> for <strong>each centimetre</strong> of cervical dilatation to guide the obstetrician to take action. For example, at 5 cm of cervical dilatation, if there is no progress &gt;6 hours, action needs to be taken.</td>\n</tr>\n<tr>\n<td>Monitoring of labour is restricted to the <strong>first stage</strong> only.</td>\n<td>Monitoring of <strong>the second stage of labour</strong> is included</td>\n</tr>\n<tr>\n<td>No section on supportive care interventions</td>\n<td>Addition of a section on <strong>supportive care</strong> of the mother- labour companionship, pain relief, oral fluid intake and posture</td>\n</tr>\n<tr>\n<td>Documentation of <strong>strength, duration, and frequency</strong> of uterine contractions</td>\n<td>Documentation of <strong>only</strong> the <strong>duration and frequency of uterine contractions</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Note</strong>: Previously the answer to the question was 4 cm (according to the modified WHO patograph). However, this information is outdated, therefore the answer to this question has been revised per the latest WHO guidelines. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/719c60870fc947ccaf5225fb3f2ffd2bx724x1024.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6619",
      "difficulty": "easy"
    },
    {
      "text": "Identify the grip shown in the image below:",
      "choices": [
        {
          "id": 1,
          "text": "Pawlik's grip"
        },
        {
          "id": 2,
          "text": "Lateral grip"
        },
        {
          "id": 3,
          "text": "Pelvic grip"
        },
        {
          "id": 4,
          "text": "Fundal grip"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The Leopold manoeuvre shown in the image is the <strong>lateral grip</strong>.&nbsp;It assesses&nbsp;<strong>fetal orientation</strong>.</p>\n<p>Leopold's manoeuvres help assess the fetal pole, lie, presenting part, engagement, and attitude of the fetal head. They are as follows:</p>\n<ol>\n<li><strong>Fundal grip </strong>(first Leopold):\n<ul>\n<li>Assesses the uterine&nbsp;<strong>fundus</strong>.</li>\n<li>Helps in identification of <strong>fetal lie</strong> and determination of fetal pole at the fundus.</li>\n<li>The<strong>&nbsp;</strong>breech<strong>&nbsp;</strong>is felt as a<strong>&nbsp;</strong>large, irregular mass.&nbsp;</li>\n<li>The<strong>&nbsp;</strong>head<strong>&nbsp;</strong>feels<strong>&nbsp;</strong>hard and round<strong>&nbsp;</strong>and is<strong>&nbsp;</strong>more mobile.<strong><br /><br /></strong></li>\n</ul>\n</li>\n<li><strong>Lateral grip </strong>(second Leopold):&nbsp;\n<ul>\n<li>Assesses the fetal<strong> orientation</strong>.</li>\n<li>The palms are placed on either side of the maternal abdomen, and gentle but deep pressure is exerted.</li>\n<li>The <strong>back</strong> is felt on one side as a <strong>hard</strong>, resistant structure.</li>\n<li>The <strong>fetal extremities</strong> are felt on the other side as <strong>numerous</strong> small, <strong>irregular, mobile </strong>parts are felt.</li>\n<li>Fetal orientation can be determined by noting whether the back is directed anteriorly, transversely, or posteriorly.</li>\n<li>The <strong>position </strong>of the<strong> anterior shoulder</strong> is mainly assessed by this grip.<br /><br /></li>\n</ul>\n</li>\n<li><strong>Pawlik's grip </strong>/ 1st pelvic grip (third Leopold):\n<ul>\n<li>Assesses the <strong>presenting</strong> <strong>part</strong>.</li>\n<li>The thumb and fingers of one hand grasp the lower portion of the maternal abdomen just above the symphysis pubis.</li>\n<li>If the presenting part is not engaged, a movable mass will be felt,&nbsp;usually the head.<br /><br /></li>\n</ul>\n</li>\n<li><strong>Deep pelvic grip </strong>/ 2nd pelvic grip (fourth Leopold):\n<ul>\n<li>Assesses the <strong>engagement</strong> and attitude of the fetal head.</li>\n<li>The examiner faces the mother's feet, and the fingertips of both hands are positioned on either side of the presenting part.</li>\n<li>They exert inward pressure and then slide along the axis of the pelvic inlet.<br /><br /></li>\n</ul>\n</li>\n</ol>\n<table>\n<tbody>\n<tr>\n<td><strong>Leopold</strong></td>\n<td><strong>Grip</strong></td>\n<td><strong>Importance</strong></td>\n</tr>\n<tr>\n<td><strong>First</strong></td>\n<td>Fundal</td>\n<td>To know which fetal pole occupies the uterine fundus.</td>\n</tr>\n<tr>\n<td><strong>Second</strong></td>\n<td>Lateral/Umbilical</td>\n<td>To know the fetal back and extremities&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Third</strong></td>\n<td>Pawlik&nbsp;</td>\n<td>\n<p>To know the presenting fetal part in respect to the true pelvis</p>\n</td>\n</tr>\n<tr>\n<td><strong>Fourth</strong></td>\n<td>Pelvic</td>\n<td>\n<p>To determine the degree of descent.</p>\n<p>If the head has already descended into the pelvis, the anterior shoulder or the space created by neck may be differentiated readily from the head</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e215ce79339c433da605c48ea10b4cc7x600x3241.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8458a76c48c74ed79c1fe4737080668b.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6620",
      "difficulty": "easy"
    },
    {
      "text": "Identify the fetal position in the given image.",
      "choices": [
        {
          "id": 1,
          "text": "Right occipito-posterior"
        },
        {
          "id": 2,
          "text": "Left occipito-anterior"
        },
        {
          "id": 3,
          "text": "Left occipito-posterior"
        },
        {
          "id": 4,
          "text": "Right occipito-anterior"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In the given vertex presentation, the fetal position is <strong>right occipitoanterior.</strong></p>\n<p><strong>Fetal position</strong> refers to the relation of the <strong>denominator </strong>(arbitrary <strong>bony</strong> fixed point on the presenting part), with respect to different <strong>quadrants</strong> of the maternal pelvis. In vertex presentation, the denominator is taken as the occiput (which is close to the triangular posterior fontanelle).</p>\n<p>To determine the fetal position the following two steps are followed:</p>\n<ol>\n<li>Determine the <strong>direction</strong> in which the occiput is facing:\n<ul>\n<li>Towards the pubic symphysis - <strong>occipito-anterior</strong></li>\n<li>Towards the sacral promontory - <strong>occipito-posterior</strong></li>\n<li>Midway between pubic symphysis and sacral promontory - <strong>occipito-transverse&nbsp;</strong></li>\n</ul>\n</li>\n<li>Determine if the occiput is facing the <strong>left</strong> or the <strong>right</strong> in relation to the materal pelvis</li>\n</ol><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8feae85a259d42049a433d013700e433x1280x1372.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/83f5f071364a43349a67fb91e84b3fa1.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6621",
      "difficulty": "easy"
    },
    {
      "text": "A midwife is examining a pregnant woman in labour when she noticed that the cord is prolapsed. What should be the next immediate step of management?",
      "choices": [
        {
          "id": 1,
          "text": "Gently replace the cord inside the vagina"
        },
        {
          "id": 2,
          "text": "Inform the doctor and shift to OT"
        },
        {
          "id": 3,
          "text": "Put her in Trendelenberg position"
        },
        {
          "id": 4,
          "text": "Do vaginal examination and find the fetal presentation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In this scenario the midwife should put the pregnant women in a <strong>Trendelenburg position</strong> or in an exaggerated and <strong>elevated Sims&rsquo; position</strong> with a pillow or wedge under the hip or thigh.</p>\n<p><strong>Caesarean section</strong> is the recommended<strong> treatment of choice</strong> for cord prolapse. Prior to performing the procedure, several measures can be taken to alleviate cord compression. These measures involve:</p>\n<ul>\n<li>Manually elevating the fetal presenting part using two fingers or the entire hand through the vagina</li>\n<li>Positioning the patient in <strong>steep Trendelenburg, exaggerated Sim's position, or knee-chest position</strong></li>\n<li>Filling the bladder with 500&ndash;700 cc or more of saline (known as the <strong>Vagos method</strong>)</li>\n</ul>\n<p>After the diagnosis of cord prolapse is made, it is crucial <strong>not to attempt cord replacement</strong>. Such attempts are not only ineffective but also result in the inevitable rupture of the membranes, leading to cord prolapse.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0dc37cf41518466b91e256c25f641497x1280x1870.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6622",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old patient comes with repeated infections of trichomonas vaginitis, her physician advises for a Pap smear. She asks you regarding the purpose of this test. What would be your appropriate response?",
      "choices": [
        {
          "id": 1,
          "text": "It is a screening test for cervical cancer"
        },
        {
          "id": 2,
          "text": "It is a diagnostic test for trichomonas infection"
        },
        {
          "id": 3,
          "text": "It helps to diagnose cancer in her genital tract"
        },
        {
          "id": 4,
          "text": "It helps to diagnose other associated genital infections in her"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A pap smear is a <strong>screening test</strong> for cervical <strong>cancer</strong>. It is not a diagnostic test (option C). The presence of abnormal cells/ a positive test requires further evaluation by colposcopy, cervical biopsy, or fractional curettage.&nbsp;</p>\n<p>If trichomonas is reported from Pap testing, it should be confirmed by saline microscopic preparation (option B).&nbsp;</p>\n<p>Cervical cancer<strong> screening</strong> should start at <strong>age 21</strong>. Women aged<strong> 21-29</strong> should have a<strong> Pap smear every 3 years</strong>, while women aged<strong> 30-65</strong> should have both <strong>HPV and Pap co-test</strong> every <strong>5 years</strong>.&nbsp;Women should stop having cervical cancer screening after the age of <strong>65 years</strong>. If suspicious PAP, screening till 75 years. HIV+ women should have annual checkups until three consecutive negative tests followed by testing every 3 years for life.</p>\n<p>Pap testing should be done <strong>prior</strong> to <strong>vaginal examination.&nbsp;</strong>Lubricants should not be used and the&nbsp;patient should not be menstruating during the pap test. The patient should not have intercourse 24hrs prior to the test. The ideal <strong>time</strong> is around <strong>ovulation</strong>.&nbsp;</p>\n<p><strong>Procedure</strong>:</p>\n<ul>\n<li>The patient is put in a <strong>dorsal</strong> position, and the labia are parted</li>\n<li><strong>Cusco&rsquo;s</strong> self-retaining <strong>speculum</strong> is introduced</li>\n<li>The <strong>squamocolumnar junction</strong> is scraped with <strong>Ayer&rsquo;s</strong> <strong>spatula</strong>:\n<ul>\n<li>Bifid end - ectocervical sample</li>\n<li>Blunt end - vaginal cytology</li>\n</ul>\n</li>\n<li><strong>Endocervix</strong> is scraped with a <strong>cytobrush</strong></li>\n<li>The sample is spread on <strong>a</strong> <strong>glass slide</strong></li>\n<li>The slide is immediately fixed using <strong>95%</strong> <strong>ethyl</strong> <strong>alcohol</strong></li>\n<li>Stained with Papanicolau stain or short-duration<strong>&nbsp;</strong>Papanicolau stain (SPS).</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/af717526ba7c45ce810e6bbe8f7409bex1280x4631.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/61db0cacf41240c59c87765886aff277x1280x2262.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Management of CIN</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1f5d51f1183f4d35857dd881e7f7f708x1280x1886.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6623",
      "difficulty": "easy"
    },
    {
      "text": "Modified Robson's classification class 1 includes:",
      "choices": [
        {
          "id": 1,
          "text": "Nulliparous, singleton, cephalic, induced labour"
        },
        {
          "id": 2,
          "text": "Nulliparous, singleton, cephalic, spontaneous labour"
        },
        {
          "id": 3,
          "text": "Multiparous without previous CS, spontaneous labour"
        },
        {
          "id": 4,
          "text": "Multiparous without previous CS, induced/CS before labour"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Class 1</strong> of modified Robson's classification includes <strong>nullipara</strong>, equal to or <strong>&gt;37</strong> weeks, <strong>single</strong>, <strong>cephalic,</strong> <strong>spontaneous labor</strong>.</p>\n<p>It is the most widely accepted classification system available for analyzing characteristics of delivering women worldwide.&nbsp;It consists of <strong>10 patient population</strong> categories.&nbsp;The basis for these categories include:&nbsp;</p>\n<ul>\n<li>Parity</li>\n<li>Onset of labor and mode of delivery</li>\n<li>Gestational age</li>\n<li>Fetal presentation&nbsp;</li>\n<li>No. of fetuses</li>\n</ul>\n<p>The <strong>modified Robson system</strong> classification is as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class 1</strong></td>\n<td>Nullipara, equal to or &gt;37 weeks, single, cephalic, spontaneous labor</td>\n</tr>\n<tr>\n<td><strong>Class 2</strong></td>\n<td>\n<p>Nullipara, equal to or &gt;37 weeks, single, cephalic</p>\n<p>&nbsp;<strong>2a:</strong> induced labor&nbsp; <strong>2b:</strong> CS before labor</p>\n</td>\n</tr>\n<tr>\n<td><strong>Class 3</strong></td>\n<td>Multipara, equal to or &gt;37 weeks, single, cephalic, spontaneous labor (excludes previous CS)</td>\n</tr>\n<tr>\n<td><strong>Class 4</strong></td>\n<td>Multipara, equal to or &gt;37 weeks, single, cephalic&nbsp; &nbsp;<strong>4a:</strong> induced labor <strong>4b:</strong> CS before labor</td>\n</tr>\n<tr>\n<td><strong>Class 5</strong></td>\n<td>Multipara, previous CS, equal to or &gt;37 weeks, single, cephalic</td>\n</tr>\n<tr>\n<td><strong>Class 6</strong></td>\n<td>Nullipara, single, breech</td>\n</tr>\n<tr>\n<td><strong>Class 7</strong></td>\n<td>Multipara, single, breech (including previous CS)</td>\n</tr>\n<tr>\n<td><strong>Class 8</strong></td>\n<td>Multiple pregnancies (with or without previous CS)</td>\n</tr>\n<tr>\n<td><strong>Class 9</strong></td>\n<td>Singleton pregnancy, oblique/transverse lie (with or without previous CS)</td>\n</tr>\n<tr>\n<td><strong>Class 10</strong></td>\n<td>&nbsp;Single, cephalic &lt;37 weeks (including previous CS)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6624",
      "difficulty": "easy"
    },
    {
      "text": "A pregnant woman has cramps in her legs. What will you suggest her to relieve the pain?",
      "choices": [
        {
          "id": 1,
          "text": "Extend knee and dorsiflex foot"
        },
        {
          "id": 2,
          "text": "Flex knee and dorsiflex foot"
        },
        {
          "id": 3,
          "text": "Extend knee and plantar flex foot"
        },
        {
          "id": 4,
          "text": "Flex knee and plantar flex foot"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Extension at</strong>&nbsp;the<strong> knee</strong> joint and <strong>dorsiflexion at </strong>the<strong> ankle</strong> joint helps in <strong>stretching the calf muscles</strong> which <strong>relieves the pain</strong>.&nbsp;</p>\n<p><strong>Leg cramps</strong> are minor ailments during pregnancy mostly&nbsp;due to a&nbsp;<strong>deficiency</strong> of diffusible serum <strong>calcium</strong> or <strong>elevation</strong> of serum <strong>phosphorus</strong>. <strong>Management</strong> includes <strong>massaging</strong> <strong>the leg</strong>, stretching exercises, application of local heat, and <strong>supplementation</strong> of vitamin B1 and <strong>calcium</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6625",
      "difficulty": "medium"
    },
    {
      "text": "A woman in labour presented to the ER. A vaginal breech delivery was planned for her. What statement regarding the management is false?",
      "choices": [
        {
          "id": 1,
          "text": "Breech identified for the first time during delivery is a contraindication for vaginal delivery"
        },
        {
          "id": 2,
          "text": "Breech delivery is done in an hospital where a facility for emergency cesarean delivery is available"
        },
        {
          "id": 3,
          "text": "Continous FHR monitoring is required for breech delivery during labour"
        },
        {
          "id": 4,
          "text": "Should be done by a skilled obstetrician"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Breech</strong> identified for the <strong>first time during delivery</strong> is <strong>not a contraindication</strong> for <strong>normal delivery</strong>.&nbsp;</p>\n<p><strong>Vaginal breech delivery</strong> is considered when:</p>\n<ul>\n<li><strong>Fetal weight</strong> is between <strong>1.5 kg</strong> and <strong>3.5 kg</strong></li>\n<li>There is an adequate pelvis</li>\n<li>The presentation is <strong>frank breech</strong></li>\n<li>The <strong>fetal head </strong>is<strong> flexed</strong></li>\n<li>There are no medical or obstetric complications</li>\n<li><strong>Facilities for emergency cesarean section</strong> are available (anesthetists, neonatologists) (option B)</li>\n<li>Facilities for <strong>continuous labor monitoring </strong>are available (option C)</li>\n<li>A <strong>skilled obstetrician </strong>is present (option D)</li>\n<li>Detailed informed consent has been obtained, explaining the risks of vaginal breech delivery</li>\n</ul>\n<p><strong>Cesarean delivery for breech </strong>presentation is considered in the following cases:</p>\n<ul>\n<li>Lack of operator experience</li>\n<li>Patient's request for cesarean delivery</li>\n<li>Prior perinatal death or neonatal birth trauma</li>\n<li>Large fetus: &gt; 3800 to 4000 g</li>\n<li>Severe IUGR, term weight &lt;2.5kg to 2.8kg</li>\n<li>Incomplete breech presentation</li>\n<li>Oligohydramnios</li>\n<li>Fetal anomaly incompatible with vaginal delivery</li>\n<li>Hyperextended head</li>\n<li>Contracted pelvis</li>\n<li>Prior cesarean delivery</li>\n<li>Preterm breech</li>\n<li>Twins, with the first baby in the breech position</li>\n</ul>\n<div class=\"page\" title=\"Page 581\">\n<div class=\"section\">\n<div class=\"layoutArea\">&nbsp;</div>\n</div>\n</div><hr><h3>Related Pearl: Maneuvers for breech delivery</h3><p><strong>Pinard’s manoeuvre </strong></p>\n<p>It is used for the delivery of <strong>extended legs</strong> in case of breech delivery.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\"1\">Flex and abduct the popliteal fossa</li>\n<li aria-level=\"1\">Catch hold of the ankle</li>\n<li aria-level=\"1\">Pull down along with abduction</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6aa624cb6ac74df887b27ed0db3f7e85x1280x4970.JPEG\" alt=\"Pearl Image\"><p> </p>\n<p><strong>Lovset’s manoeuvre</strong></p>\n<p>It is used for the delivery of <strong>extended arms</strong> in case of a breech presentation.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\"1\">Hold the sacrum with the thumb, and the hips and pelvis with other fingers.</li>\n<li aria-level=\"1\">Turn the infant 90 degrees to bring the shoulder under pubic symphysis and deliver the anterior shoulder.</li>\n<li aria-level=\"1\">Then counter-rotate 180 degrees to engage and deliver the posterior shoulder. </li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bbd5c8755d1242329bac304aad0f9f82x1280x3105.JPEG\" alt=\"Pearl Image\"><p> </p>\n<p><strong>Modified Prague’s manoeuvre</strong></p>\n<p>It is used in breech presentations to deliver the <strong>aftercoming head</strong> when the back of the fetus fails to rotate to the symphysis.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\"1\">Grasp the shoulders of the baby from below with two fingers of one hand.</li>\n<li aria-level=\"1\">Draw the feet up and over the maternal abdomen with the other hand.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fb878bf761548269e792fc999b4e8f0x1280x1868.JPEG\" alt=\"Pearl Image\"><p> </p>\n<p><strong>Burns-Marshall method</strong></p>\n<p>It is used for delivery of <strong>aftercoming head</strong> in case of breech presentation.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\"1\">Allow the baby to hang by its own weight.</li>\n<li aria-level=\"1\">When the nape of the neck is visible under the pubic arch, grasp the baby by the ankles with a finger in between the two.</li>\n<li aria-level=\"1\">Swing the baby in an arc in an upward and forward direction.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/52d2ef75e12c458189a04107a253ae13x1280x5962.JPEG\" alt=\"Pearl Image\"><p> </p>\n<p><strong>Mauriceau-Smellie-Veit technique</strong></p>\n<p>It is another method that can be used in the delivery of <strong>aftercoming head</strong> in case of breech presentation. It is also called <strong>malar flexion and shoulder traction</strong>.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\"1\">Place the baby on the supinated left arm with limbs hanging on either side.</li>\n<li aria-level=\"1\">Place the index and middle fingers of the left hand on either side over the malar bones.</li>\n<li aria-level=\"1\">Place the ring and the little finger of the pronated right hand on the child’s right shoulder, index finger on the left shoulder and middle finger over the suboccipital region.</li>\n<li aria-level=\"1\">Traction is given in the downward and backward direction till the nape of the neck is visible.</li>\n<li aria-level=\"1\">Thereafter, the baby is carried in an upward and forward direction towards the mother’s abdomen.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ce9f096a6bee481396bcbe161cbb14a1x1280x1187.JPEG\" alt=\"Pearl Image\"><p> </p>\n<p><strong>Mnemonic:</strong></p>\n<ul>\n<li aria-level=\"1\"><strong>Extend the arm</strong> to express Love(<strong>Lovset's</strong>)</li>\n<li aria-level=\"1\">Put the fingers in <strong>popliteal</strong> fossa for <strong>Pinard's</strong>(P for P)</li>\n</ul><hr><h3>Related Pearl: External cephalic version- indications and contraindications</h3><p>External cephalic version (ECV) is done to bring the favourable cephalic pole in the lower pole of the uterus.</p>\n<p><strong>Indications:</strong></p>\n<ul>\n<li>Breech presentation</li>\n<li>Tranverse lie</li>\n</ul>\n<p><strong>Contraindications:</strong></p>\n<ul>\n<li>APH due to risk of placental separation</li>\n<li>Fetal causes- hyperextension of the neck (<em>\"</em>star-<em>gazing\"</em> position), large fetus (&gt;3.5 kg), congenital abnormalities, dead fetus, fetal compromise</li>\n<li>Obstetric complications- severe pre-eclampsia, obesity, elderly primigravida, bad obstetric history&nbsp;</li>\n<li>Rh alloimmunization</li>\n<li>Multiple pregnancy</li>\n<li>Ruptured membrane</li>\n<li>Congenital malformations of uterus</li>\n<li>Abnormal CTG</li>\n<li>Contracted pelvis</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6626",
      "difficulty": "easy"
    }
  ]
}